Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | DRD4 | P21917 | 2/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.49 |
| ▸ | RARB | P10826 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | LTA4H | P09960 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7922047 | 0.96 | MAPT (0.49) | KDM4ERECQLTDP1MAPTDRD4 | |
| SCHEMBL7254241 | 0.92 | MAPT (0.51) | KDM4ERECQLMAPTDRD4DRD2 | |
| SCHEMBL7929523 | 0.91 | NR5A1 (0.55) | KDM4ERECQLTDP1DRD4DRD2 | |
| SCHEMBL6516509 | 0.90 | RARB (0.57) | KDM4ERECQLTDP1DRD4DRD2 | |
| SCHEMBL7930618 | 0.89 | NR5A1 (0.58) | KDM4ERECQLTDP1MAPTRARB | |
| SCHEMBL11134859 | 0.87 | RARB (0.54) | KDM4EMAPTDRD4DRD2DRD3 | |
| SCHEMBL917938 | 0.86 | NR5A1 (0.62) | KDM4ERECQLTDP1MAPTDRD4 | |
| SCHEMBL916469 | 0.86 | LTA4H (0.57) | KDM4ETDP1MAPTDRD4DRD2 | |
| SCHEMBL14134296 | 0.86 | MAPT (0.60) | KDM4EMAPTDRD4DRD2DRD3 | |
| SCHEMBL681577 | 0.86 | MAPT (0.60) | KDM4EMAPTDRD4DRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230381326-A1 | DRUG DELIVERY SYSTEM FOR TREATING DISEASE | SDG, LLC | 2023-11-30 | — | — | US | disclosed |
| US-11666654-B2 | Drug delivery system for treating disease | SDG LLC (US) | 2023-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11666654-B2 | Drug delivery system for treating disease | HPGDS, VHL, HPSE | KDM4E 2841/4885RECQL 3383/4885TDP1 2866/4885 |
| US-20230381326-A1 | DRUG DELIVERY SYSTEM FOR TREATING DISEASE | HPGDS, VHL, HPSE | KDM4E 2841/4885RECQL 3383/4885TDP1 2866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.